MYD88 and metabolic dysfunction-associated steatohepatitis: Moreover, CGA directly binds to myeloid differentiation primary response 88 (MyD88) to competitively block TLR4/MyD88 interaction, thereby reducing LPS-TLR4-MyD88-mediated hepatic inflammation during NASH progression [73].